Celixir (formerly known as Cell Therapy Ltd.) is a private British regenerative medicine company that discovers and develops life-saving and life-altering regenerative medicines for patients with the greatest medical need. Celixir, founded in 2009, is made up of a world-class team of scientists and biopharmaceutical executives, led by Nobel Laureate Professor Sir Martin Evans and former Roche Global Head of Emerging Technologies, Ajan Reginald. Celixir’s unique platform technology allows us to adopt an ‘off-the-shelf’ approach to deliver regenerative medicines to patients.
Looking for a particular Celixir employee's phone or email?
The Celixir annual revenue was $4 million in 2026.
3 people are employed at Celixir.
Celixir is based in Cardiff, Wales.
The NAICS codes for Celixir are [541713, 54, 541, 54171, 5417].
The SIC codes for Celixir are [873, 87].